U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209046) titled 'Impact of Probiotic (UltraFlora(R) Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.' on Sept. 18.
Brief Summary: This is a randomized, double-blind, double arm study involving 128 participants who will undergo a total participation period of 12 weeks.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Adults
GLP-1
Intervention:
DIETARY_SUPPLEMENT: UltraFlora(R) Triplebiotic
The duration of trial intervention and participation for an individual participant is approximately 3 months (12 weeks). Screening, during which eligibility to participate in the trial is assessed, occurs at...